AIM ImmunoTech Inc.

06/05/2026 | Press release | Archived content

DURIPANC, Mid-Year 2026 Interim Clinical Progress Update (200506)

AIM ImmunoTech Inc. published this content on June 05, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on June 08, 2026 at 12:40 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]